Nadja M Meindl-Beinker

5PUBLICATIONS
37CO-AUTHORS
Predictive and prognostic markersInnate immunityMolecular targetsChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 03, 2026
TGF-β1 and TGF-β2 family members differentially modulate tumor initiation and invasiveness of primary liver cancer in a MMP14-dependent manner.

|Oct 15, 2024
Role of WISP1 in Stellate Cell Migration and Liver Fibrosis.

Daniela González, Gisela Campos, Larissa Pütter

|May 03, 2024
The immunoglobulin superfamily ligand B7H6 subjects T cell responses to NK cell surveillance.

Michael Kilian, Mirco J Friedrich, Kevin Hai-Ning Lu

|Jan 30, 2020
TGF-β2 silencing to target biliary-derived liver diseases.

Anne Dropmann, Steven Dooley, Bedair Dewidar

|Mar 16, 2019
A multicenter open-label phase II trial to evaluate nivolumab and ipilimumab for 2nd line therapy in elderly patients with advanced esophageal squamous cell cancer (RAMONA).

Nadja M Meindl-Beinker, Johannes Betge, Tobias Gutting

Pageof 1

Frequent Collaborators

3 joint publications

Steven Dooley

2 joint publications

Thomas S Weiss

1 joint publications

Andreas Teufel

1 joint publications

Detlef Schuppan